IGLON5: A Potential Drug Target and Biomarker (G402665)

Target Name: IGLON5

NCBI ID: G402665

IGLON5

Other Name(s): Ig-like domain-containing protein ENSP00000270642 | IGLO5_HUMAN | IgLON family member 5 | hCG1651476

IGLON5: A Potential Drug Target and Biomarker

Ig-like domain-containing proteins (IDPs) are a family of transmembrane proteins that play a crucial role in various biological processes. One such protein is IGLON5, also known as ENSP00000270642. Extremely high computational accuracy and conservation of sequence have led to the prediction of a conserved protein domain in the IGLON5 protein. This domain includes an N-terminal 伪-helix, a central 尾-sheet, and a C-terminal domain. As an IDP, IGLON5 plays a key role in multiple biological processes. In cancer, neurodegenerative diseases and other chronic diseases, abnormal expression or dysfunction of IGLON5 may lead to serious health problems.

In recent years, researchers have conducted in-depth studies on IGLON5 to determine its function in organisms and its possibility as a drug target. These findings indicate that IGLON5 plays an important role in a variety of biological processes, such as cell proliferation, apoptosis, migration, and neurogenesis. In addition, IGLON5 is also closely related to the occurrence and development of various diseases, such as neurodegenerative diseases, tumors and cardiovascular diseases.

As a drug target, IGLON5 provides new opportunities for drug development. Researchers are exploring the use of small molecule compounds or large molecule drugs to interfere with the function of IGLON5 to treat various diseases. Currently, some research teams are developing drugs targeting IGLON5 in order to achieve treatment of the disease.

As a biomarker, abnormal expression or dysfunction of IGLON5 can be used as a biomarker for many diseases. For example, studies have shown that the expression level of IGLON5 is positively correlated with a variety of neurodegenerative diseases, such as Parkinson's disease, Alzheimer's disease, and multiple sclerosis. In addition, the expression level of IGLON5 is closely related to tumor occurrence and development. Therefore, using IGLON5 as a biomarker can more accurately predict disease risks and development trends.

Overall, IGLON5, as an IDP, plays a key role in organisms. By studying the function and potential of IGLON5 as a drug target, new ideas can be provided for the treatment of various diseases. At the same time, as a biomarker, IGLON5 can be used for disease risk assessment and treatment effect monitoring. With the deepening of research, we are expected to gradually reveal the secrets of IGLON5 in organisms and bring good news to human health.

Protein Name: IgLON Family Member 5

The "IGLON5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGLON5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets